Though there are no clearly defined correlates of protection against clinical malaria by these vaccines, immune mechanisms mediating protection may include interferon-γ (IFN-γ)-secreting CD8+ T cells that primarily target malaria antigens expressed on the surface of hepatocytes [7–9]. The gene discussed is IFNG; the disease is malaria.